Background Controversy persists regarding the optimal revascularization strategy for
diabetic patients with multivessel coronary artery disease (MVD). Coronary artery bypass …

This meta-analysis was undertaken to assess the efficacy and safety of coronary artery
bypass grafting (CABG) compared to drug-eluting stenting (DES) in patients with diabetes …

Background and aim Clinical trials have reported lower mortality and repeated
revascularization rate in diabetic patients treated with coronary artery bypass grafting …

Objectives: To explore the clinical performance of a strategy of revascularization by
percutaneous coronary intervention (PCI) with drug‐eluting stent (DES) in diabetic patients …

BACKGROUND: This retrospective study of prospectively collected data compared coronary
artery bypass graft (CABG) surgery to drug‐eluting stenting (DES) in diabetic patients with …

Background—Advances in coronary artery bypass grafting (CABG) surgery and
percutaneous coronary intervention (PCI) with drug-eluting stents have dramatically …

BACKGROUND: The optimal revascularization strategy for diabetic patients with multivessel
coronary artery disease (MVD) remains uncertain for lack of an adequately powered …

Background: Randomized trial data support the superiority of coronary artery bypass grafting
(CABG) surgery over percutaneous coronary intervention (PCI) in diabetic patients with …

Background Our aims were to compare coronary artery bypass grafting (CABG) and stenting
for the treatment of diabetic patients with multivessel coronary disease enrolled in the …

Objectives: We compared the 5-year outcomes of diabetic patients with multivessel disease
treated with sirolimus-eluting stents (SES), bare-metal stents (BMS), and coronary artery …